ST. LOUIS — Canopy BiosciencesTM, LLC, a leading provider of gene editing and personalized medicine technologies, announced today that it has launched two novel services for immuno-oncology and neurodegenerative disease. Both services allow researchers to assess the expression of nearly 800 disease-relevant genes in a single sample. The new Neuropathology service allows researchers to conduct […]
Canopy Biosciences launches CRISPR Complete Gene Editing Kits.
Canopy Biosciences signs deal with Array Bridge to market kits for impurity analysis.
ST. LOUIS, June 28, 2017 /PRNewswire/ — Canopy BiosciencesTM, LLC, an emerging provider of gene editing and personalized medicine technologies, announced today that it has launched a service for high throughput gene expression analysis. Based on the NanoString nCounter platform, the service works with a large array of sample types, including formats such as formalin-fixed […]
Canopy Biosciences signs agreement with Cosmo Bio to sell gene engineering products in Japan ST. LOUIS, June 22, 2017 /PRNewswire/ — Canopy BiosciencesTM, LLC (“Canopy Biosciences”), an emerging provider of gene editing and personalized medicine technologies, announced a distributor agreement with Cosmo Bio Co., Ltd. (“Cosmo Bio”) for its TUNR Flexible Gene Editing technology in […]
ST. LOUIS, March 31, 2017 /PRNewswire/ — Canopy BiosciencesTM, LLC, an emerging provider of products and services for gene editing and personalized medicine, announced today that it has entered an exclusive licensing agreement with Washington University in St. Louis and Johns Hopkins for key intellectual property around a novel technology for gene editing. The TUNRTM […]
“The rap on St. Louis’ biotech industry is that all of its startups are years away from selling products, with no big success stories yet. Don’t tell that to Ed Weinstein, co-founder and chief executive of Canopy Biosciences. Canopy is launching its first product just months after being founded, and it expects to quickly achieve […]
